NCT02506829.
Trial name or title | Financial Incentives for Smoking Treatment (FIESTA) |
Methods | Parallel‐assignment randomised controlled trial |
Participants | 182 urban veteran smokers |
Interventions | Financial incentives intervention: "Usual care in hospital, referral to a smoking cessation Quitline on discharge from hospital. Financial incentives for: a) speaking with a coach from the Smoker's Quitline ($50), b) completion of another community‐based smoking‐cessation program ($50), and/or c) use of pharmacotherapies for smoking cessation at 2 weeks ($50); and d) for smoking cessation, confirmed with the use of a cotinine test at 2 months ($150); and e) for smoking cessation, confirmed with the use of a cotinine test at 6 months after study enrollment ($250)." Control: "Usual care in hospital, referral to a smoking cessation Quitline on discharge from hospital." |
Outcomes | Primary: Self‐report and biochemically verified (by salivary cotinine) smoking abstinence at 6 months Secondary: Self‐report smoking abstinence at 6 months; use of evidence‐based treatments; quality of life (measured with EQ5‐D); short‐ and long‐term return on investment (cost analysis) |
Starting date | July 2015 |
Contact information | Dr Joseph Ladapo JLadapo@mednet.ucla.edu Dr Scott Sherman Scott.Sherman@nyumc.org |
Notes |